VERACYTE, INC. Other Non-Current Liabilities
VERACYTE, INC. (VCYT) had Other Non-Current Liabilities of $0 as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-02-26
- 2025-12-31: Other Liabilities, Noncurrent $0.00.
- 2025-09-30: Other Liabilities, Noncurrent $0.00.
- 2025-06-30: Other Liabilities, Noncurrent $508.00K.
- 2025-03-31: Other Liabilities, Noncurrent $446.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $508.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $446.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $411.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $571.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $540.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $528.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $786.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $776.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $792.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $791.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $931.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.15M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.21M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $1.38M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.41M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.89M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |